Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (2): 122-127.doi: 10.6040/j.issn.1673-3770.0.2022.516

• Review • Previous Articles     Next Articles

Expression and clinical significance of IL-29 and TLR4 in eosinophil infiltrated nasal polyps

YAN Huijuan, XIAO Xuping, ZHONG Yu   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University / Hunan provincial People's Hospital, Changsha 410005, Hunan, China
  • Online:2024-03-20 Published:2024-03-29

PDF (PC)

15

Abstract: Nasal polyp is a chronic inflammatory disease of the nasal cavity and the nasal sinus mucosal epithelium. It is a common condition in otorhinolaryngology. Nasal polyp result from inflammation and fibrin deposition and are related to epithelial barrier dysfunction. Although endoscopic sinus surgery is relatively mature, some nasal polyps are difficult to treat and the condition has a high recurrence rate. Previous studies reported a 50% recurrence in patients with. Interleukin-29(IL-29), a newly discovered member of type Ⅲ interferon, mediates signal transduction by binding to its receptor complex, activates downstream signalling pathways, and induces the generation of inflammatory components. Toll-like receptor 4(TLR4), a member of the Toll-like receptor family, is involved in innate immunity and mediates inflammatory responses by recognizing lipopolysaccharide or bacterial endotoxins. Studies have shown that the expression of TLR4 in patients with nasal polyps is significantly increased. Although IL-29 and TLR4 are important in regulating inflammatory responses, their relationship and their correlation with eosinophil infiltration in patients with nasal polyps are unclear. An exploration of the clinical indicators related to eosinophil infiltration in nasal polyps may provide new ideas for the diagnosis and treatment of nasal polyps.

Key words: Eosinophil, Nasal polyp, Interleukin-29, Toll-like receptor 4

CLC Number: 

  • R765.25
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi: 10.3760/cma.j.issn.1673-0860.2019.02.001
[2] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. doi:10.4193/Rhin20.600
[3] 黄丹怡, 张婷, 陈静, 等. 上皮屏障在慢性鼻窦炎伴鼻息肉中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 78-83. doi: 10.6040/j.issn.1673-3770.0.2021.583 HUANG Danyi, ZHANG Ting, CHEN Jing, et al. Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 78-83. doi: 10.6040/j.issn.1673-3770.0.2021.583
[4] 陶丹丹, 董红军, 褚云锋, 等. 慢性鼻-鼻窦炎伴鼻息肉患者组织嗜酸性粒细胞与嗅觉功能障碍的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388 TAO Dandan, DONG Hongjun, CHU Yunfeng, et al. Correlation between eosinophils and olfactory dysfunction in patients with CRSwNP after nasal operation[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388
[5] 王成硕, 娄鸿飞, 孟一帆, 等. 组织嗜酸粒细胞增多对慢性鼻-鼻窦炎伴鼻息肉复发的预测价值研究[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(4): 268-272. doi:10.3760/cma.j.issn.1673-0860.2016.04.005 WANG Chengshuo, LOU Hongfei, MENG Yifan, et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(4): 268-272. doi:10.3760/cma.j.issn.1673-0860.2016.04.005
[6] 谷钰, 万鑫, 肖自安. 中性粒细胞和嗜酸性粒细胞在慢性鼻窦炎中的相互影响及临床治疗思考[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 56-63. doi: 10.6040/j.issn.1673-3770.0.2021.513 GU Yu, WAN Xin, XIAO Zian. The interaction between neutrophils and eosinophils in chronic rhinosinusitis and the implications on treatment options[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 56-63. doi: 10.6040/j.issn.1673-3770.0.2021.513
[7] Ouyang WJ, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annu Rev Immunol, 2011, 29: 71-109. doi:10.1146/annurev-immunol-031210-101312
[8] Wang SF, Gao XQ, Xu YN, et al. Elevated plasma level of interferon-λ1 in chronic spontaneous urticaria: upregulated expression in CD8+ and epithelial cells and induction of inflammatory cell accumulation[J]. Mediators Inflamm, 2016: 5032051. doi:10.1155/2016/5032051
[9] Chrysanthopoulou A, Kambas K, Stakos D, et al. Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation[J]. J Pathol, 2017, 243(1): 111-122. doi:10.1002/path.4935
[10] Kawai T, Akira S. TLR signaling[J]. Semin Immunol, 2007, 19(1): 24-32. doi:10.1016/j.smim.2006.12.004
[11] Kesici GG, Kargın Kaytez S, Özda??塂 T, et al. Association of toll-like receptor polymorphisms with nasal polyposis[J]. Ear Nose Throat J, 2021, 100(1): NP26-NP32. doi:10.1177/0145561319859305
[12] Lin TY, Chiu CJ, Kuan CH, et al. IL-29 promoted obesity-induced inflammation and insulin resistance[J]. Cell Mol Immunol, 2020, 17(4): 369-379. doi: 10.1038/s41423-019-0262-9
[13] Duan T, Du Y, Xing C, et al. Toll-like receptor signaling and its role in cell-mediated immunity[J]. Front Immunol, 2022, 13: 812774. doi: 10.3389/fimmu.2022.812774
[14] Taziki MH, Azarhoush R, Taziki MM, et al. Correlation between HMGB1 and TLR4 expression in sinonasal mucosa in patients with chronic rhinosinusitis[J]. Ear Nose Throat J, 2019, 98(10): 599-605. doi:10.1177/0145561319858915
[15] Xu DH, Yan SS, Wang HJ, et al. IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis[J]. Cell Physiol Biochem, 2015, 37(1): 27-34. doi:10.1159/000430330
[16] Sheppard P, Kindsvogel W, Xu WF, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R[J]. Nat Immunol, 2003, 4(1): 63-68. doi:10.1038/ni873
[17] Wang JM, Huang AF, Xu WD, et al. Insights into IL-29: emerging role in inflammatory autoimmune diseases[J]. J Cell Mol Med, 2019, 23(12): 7926-7932. doi:10.1111/jcmm.14697
[18] Gupta S, Yamada E, Nakamura H, et al. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's Disease[J]. medRxiv, 2023: 2023.08.16.23294130. doi: 10.1101/2023.08.16.23294130
[19] 颜兴艳. 恩替卡韦治疗的慢乙肝患者加用PegIFNα-2a的临床疗效及IL-29在乙肝病毒清除中的意义[D]. 南昌: 南昌大学, 2018
[20] Jordan WJ, Eskdale J, Srinivas S, et al. Human interferon lambda-1(IFN-lambda1/IL-29)modulates the Th1/Th2 response[J]. Genes Immun, 2007, 8(3):254-261. doi: 10.1038/sj.gene.6364382
[21] Wolk K, Witte K, Witte E, et al. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis[J]. Sci Transl Med, 2013, 5(204): 204ra129. doi:10.1126/scitranslmed.3006245
[22] Li Y, Gao Q, Yuan X, et al. Adenovirus expressing IFN-λ1(IL-29)attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma[J]. Int Immunopharmacol, 2014, 21(1): 156-162. doi: 10.1016/j.intimp.2014.04.022
[23] 阮鸯. 白细胞介素-29在鼻息肉组织中的表达及意义[D]. 太原: 山西医科大学, 2019
[24] Medzhitov R, Preston-Hurlburt P, Jr Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397. doi:10.1038/41131
[25] Schuster JM, Nelson PS. Toll receptors: an expanding role in our understanding of human disease[J]. J Leukoc Biol, 2000, 67(6): 767-773
[26] Duan T, Du Y, Xing C, et al. Toll-Like receptor signaling and its role in cell-mediated immunity[J]. Front Immunol, 2022, 13: 812774. doi: 10.3389/fimmu.2022.812774
[27] 崔粲. HIF-1α与TLR4在鼻息肉组织中的表达及相互关系[D]. 太原: 山西医科大学, 2018
[28] 张国华. Toll样受体在真菌性鼻—鼻窦炎中的表达及意义[D]. 广州: 南方医科大学, 2008
[29] Shukur W, Alyaqubi K, Dosh R, et al. Association of Toll-like receptors 4(TLR-4)gene expression and polymorphisms in patients with severe asthma[J]. J Med Life, 2021, 14(4): 544-548. doi:10.25122/jml-2021-0173
[30] 刘亮亮, 文华, 杨瑾, 等. TLR4/NF-κB通路在慢性鼻-鼻窦炎伴鼻息肉和不伴鼻息肉的黏膜上皮修复机制中的作用[J]. 医学信息, 2022, 35(15): 39-45. doi:10.3969/j.issn.1006-1959.2022.15.008 LIU Liangliang, WEN Hua, YANG Jin, et al. The role of TLR4/NF-κB signaling pathway in the repair of mucosal epithelium in chronic sinusitis with nasal polyps and without nasal polyps[J]. Medical Information, 2022, 35(15): 39-45. doi:10.3969/j.issn.1006-1959.2022.15.008
[31] 王爱平, 孙海波. 慢性鼻-鼻窦炎伴鼻息肉患者鼻黏膜组织中YKL-40及 TLR4的表达变化及意义[J]. 山东医药, 2016, 56(21): 88-89. doi:10.3969/j.issn.1002-266X.2016.21.036 WANG Aiping, SUN Haibo. Expression changes and significance of YKL-40 and TLR4 in nasal mucosa of patients with chronic rhinosinusitis and nasal polyps[J]. Shandong Medical Journal, 2016, 56(21): 88-89. doi:10.3969/j.issn.1002-266X.2016.21.036
[32] Andor H, Maria K, Edit K, et al. Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis[J]. Eur Arch Oto Rhino Laryngol, 2016, 273(7): 1779-1788
[33] 马越, 吴帅, 蔡晓岚, 等. 类几丁质酶YKL-40及Toll样受体4在慢性鼻-鼻窦炎伴鼻息肉与不伴鼻息肉患者中表达的差异[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(4): 300-305. doi:10.3760/cma.j.issn.1673-0860.2015.04.008 MA Yue, WU Shuai, CAI Xiaolan, et al. Expression of YKL-40 and TLR4 in patients with chronic rhinosinusitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2015, 50(4): 300-305. doi:10.3760/cma.j.issn.1673-0860.2015.04.008
[34] Taziki MH, Azarhoush R, Taziki MM, et al. Correlation between HMGB1 and TLR4 expression in sinonasal mucosa in patients with chronic rhinosinusitis[J]. Ear Nose Throat J, 2019, 98(10): 599-605. doi:10.1177/0145561319858915
[35] Xu DH, Yan SS, Wang HJ, et al. IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis[J]. Cell Physiol Biochem, 2015, 37(1): 27-34. doi:10.1159/000430330
[36] Andreakos E, Zanoni I, Galani IE. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control[J]. Curr Opin Immunol, 2019, 56: 67-75. doi: 10.1016/j.coi.2018.10.007
[37] Roelofs MF, Wenink MH, Brentano F, et al. Type I interferons might form the link between Toll-like receptor(TLR)3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis(RA)[J]. Ann Rheum Dis, 2009, 68(9): 1486-1493. doi:10.1136/ard.2007.086421
[38] Wang F, Xu L, Feng X, et al. AB0040 IL-29 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via JAK/STAT3 and MAPK/NF-κB signaling pathways[J]. Ann Rheum Dis, 2013, 72(Suppl 3): A797-A798. doi:10.1136/annrheumdis-2013-eular.2363
[39] Zhang H, Song B, He S. Interleukin 29 activates expression of tissue inhibitor of metalloproteinase 1 in macrophages via tolllike receptor 2[J]. Mol Med Rep, 2018, 17(6):8363-8368. doi: 10.3892/mmr.2018.8865
[1] LUN Yingjun, CHEN Chen, GAO Hongcheng, FAN Qinglin, TAI Renqing. Role of Toll-like receptor 4/nuclear transcription factor-κB channels in diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 163-168.
[2] CHEN Kun, LU Hui, LI Lei, ZHANG Fan, YANG Jun, HUANG Qi. Multicentric plasma cell type Castleman disease involving multiple sites in children: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 54-58.
[3] SUN Xiwen, LUO Chunyu, LI Zhipeng, ZHANG Weitian. Role of ferroptosis in inflammatory diseases of the respiratory tract: a review of recent advances [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 24-32.
[4] WANG Lixue, ZENG Yi, WANG Lixin, PENG Xianbing. Clinical observation of the effect of infiltrating Biprofen Gelatin Sponge after functional endoscopic sinus surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 16-25.
[5] ZHU Yu, ZHU Xinhua. Research progress on the role of TH2 cytokines in Type2 chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 156-161.
[6] CUI Ning, WANG Yunmeng, YANG Jingpu. Research progress on the role and regulatory mechanism of group 2 innate lymphoid cells in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 153-159.
[7] AO Tian,CHENG Lei. An endotype study of chronic rhinosinusitis with nasal polyps and precise control and treatment under the guidance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 7-14.
[8] LIANG Xu,SHI Li. Research progress in biologic targeted drug therapy for chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 30-35.
[9] SHI Shuai, ZHENG Quan,CHENG Lei. Research advances of dupilumab in the treatment of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 36-42.
[10] YI Ruonan,CHEN Fuquan. Eosinophils and Olfactory Dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 50-55.
[11] GU Yu, WAN Xin,XIAO Zi'an. The interaction between neutrophils and eosinophils in chronic rhinosinusitis and the implications on treatment options [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 56-63.
[12] LIN Hai, ZHU Ying,ZHANG Weitian. The roles of ion channels in the pathogenesis of chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 64-70.
[13] HUANG Danyi, ZHANG Ting,CHEN Jing, ZHANG Wei. Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 78-83.
[14] LI Jiani, ZHU Dongdong,MENG Cuida. The role of epigenetics in the pathogenesis of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 84-91.
[15] YU Longgang,JIANG Yan. Research progress on the correlation between nasal bacterial microbiome and chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 92-97.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] YANG Changliang,HUANG Zhiwu,YAO Hangqi,ZHU Yong,SNU Yi . Study on auditory brainstem response[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 9 -13 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[3] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 90 -91 .
[4] LIU Da-yu,PAN Xin-liang,LEI Da-peng,ZHANG Li-qiang,LUAN Xin-yong . Surgical treatment for medial wall pyriform sinus cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 8 -11 .
[5] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(2): 188 -188 .
[6] LIU Yan,LIU Xin-yi,WANG Jin-ping,LI Da-jian . Measurement of the posterior tympanum and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 218 -221 .
[7] ZHAO Min,WANG Shou-sen,ZHEN Ze-nian,CHEN Xian-ming,WANG Mao-xin . Sphenoid sinus and trans-sphenoid surgery under nasal endoscopy and microscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 244 -245 .
[8] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 252 -252 .
[9] WANG Hong-xia,WANG Peng-cheng . Expression of NSE,S100 and GFAP in retinoblastoma and its clinical significance[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 263 -264 .
[10] HUANG Fang,HUANG Hai-qiong,HUANG Jian-qiang,HE He-fan . Bronchoscopic video supervision system in infant bronchial foreign bodies[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 276 -277 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd